Cybercriminals are increasingly targeting healthcare organizations due to the vast amounts of sensitive information they store. This data includes patients' financial details, medical records, and other personal information, which fetch high prices on the dark web.
The Am Law 100 ranks the 100 largest law firms in the United States and offers dynamic data exploration on law firms, companies, lawyers, and industry trends. It provides real-time notifications on new state and federal litigation, unlimited access to complaints, expert case summaries, and AI-driven trend analysis.
Pfizer has requested a temporary restraining order to prevent Metsera from breaking its contract and working with Novo Nordisk instead. The move aims to protect Pfizer's ongoing acquisition of Metsera.
"A reasonable juror could find that the defendants’ 'blaming supply,' making uncompetitively high bids and falsely citing production costs for increased prices were aimed at concealing their alleged conspiracy," the court ruled.
Pfizer accuses Novo Nordisk of trying to "catch and kill" Metsera to eliminate potential competition for its obesity drugs Ozempic and Wegovy.
This situation highlights how data breaches expose healthcare organizations to risks and their legal battles impact competition in the pharmaceutical industry.
Would you like the summary to be more detailed or more concise?